Clinical Trials Directory

Trials / Completed

CompletedNCT01449136

Use of Antibacterial Cement in Infected Dentin

Phase 1 Study of Clinical and Radiographic Success of Antibacterial Cement in Infected Dentin of Deciduous Teeth

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
University of Pernambuco · Academic / Other
Sex
All
Age
5 Years – 8 Years
Healthy volunteers
Not accepted

Summary

Dental materials with antibacterial properties can prevent the harmful effects caused by oral cariogenic bacteria. This double-blind controlled clinical trial evaluated the performance of antibacterial cement for sealing infected dentin in atraumatic restorations of primary molars.

Detailed description

The study enrolled 45 children (45 teeth) between 5 and 8 years of age, of both genders, divided into two groups. In group A (GA; n=22), the cavities were lined with conventional glass ionomer cement (Vidrion F®) and in group B (GB; n=23), with antibacterial cement (Vidrion F® containing 1% each of metronidazole, ciprofloxacin, and cefaclor). Both groups were restored with Ketac Molar Easymix®. Molars with carious lesions on the inner half of dentin without clinical or radiographic pulp damage were selected. Patients were evaluated clinically (for pain, fistulas, or mobility) and radiographically (area of caries, periapical region, and furcation of teeth) after 1, 3, 6, and 12 months.

Conditions

Interventions

TypeNameDescription
OTHERAntibacterial cementGlass ionomer cement containing 1% each of metronidazole, ciprofloxacin, and cefaclor

Timeline

Start date
2008-01-01
Primary completion
2010-02-01
Completion
2010-02-01
First posted
2011-10-10
Last updated
2011-10-10

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01449136. Inclusion in this directory is not an endorsement.